Quick Stats

Bid Price - Offer Price -
Mid Price GBX 215.80 Day Change GBX -2.40 (-1.10%)
Price Date 28 Jun 2017 Crown Rating 1
Shares Class Inc. Yield 0.10 %
Total Expense Ratio 0.00 Fund Size 48,940,100.00
Launch Date 02/01/2003 Standard Initial Charge (%) 0.00
Currency GBX ISA Eligible Yes
Annual Management Charge (%) 1.00 Sector IMA UK Equity Income
Min Investment (£) 3,000.00 Total Expense Ratio (%) 0.00
ISIN GB0033506725 Min TopUp (£) 1,000.00

Fund Objective

The Fund seeks to achieve capital growth, principally through investment in securities of US issuers

Fund Managers

Sam Peters
Sam joined the firm in 2005. Prior to joining Legg Mason, Sam worked for Fidelity Management & Research, serving as portfolio manager of the Fidelity Select Health Care Fund and the Fidelity Select Medical Equipment Fund, as well as team leader for the Health Care sector. Previously, Sam managed the Fidelity Select Electronics Fund and the Fidelity Select Banking Fund. Sam joined Fidelity in 1999 as a bank analyst. In 1996, Sam founded Samuel M. Peters Investment Advisors, an independent advisory firm. From 1992 to 1995, Sam was a financial consultant for Eppler, Guerin & Turner. Sam serves on the Board of Trustees for the Gilman School in Baltimore, Maryland, is a member of the Merchant Livestock Board and is a board member emeritus of the College of William & Mary's Endowment Committee. Sam also serves on the Board of Trustees of The Santa Fe Institute, a leading, multi-disciplinary research laboratory dedicated to developing and advancing solutions to complex problems in physical, biological and social systems. Sam earned a B.A. in economics from the College of William & Mary and an M.B.A. from the University of Chicago. He received the CFA designation in 1997.
Jean Yu
Jean co-manages the Value Equity Strategy. She has 14 years of investment industry experience. Jean joined ClearBridge, LLC (f/k/a Legg Mason Capital Management, LLC) in 2002 as a Research Analyst responsible for research in the health care sector as well as transportation logistical companies, industrial gas, and Chinese internet stocks. Previously, she worked as a Senior Business Analyst, managing consulting projects for Fortune 50 clients in the pharmaceutical industry at ISO Health Care Group. She received an MD from Beijing Medical University, an MBA from Duke University in Health Sector Management and Finance and a PhD in Molecular Biology from Columbia University. Jean received the CFA designation in 2006.